Recent Advances in Uterine Myoma and Pregnancy
10.21896/jksmch.2020.24.3.144
- Author:
Se Jin LEE
1
;
Jong Yun HWANG
Author Information
1. Department of Obstetrics and Gynecology, Kangwon National University Hospital, Kangwon National University School of Medicine, Chuncheon, Korea
- Publication Type:Review Article
- From:Journal of the Korean Society of Maternal and Child Health
2020;24(3):144-153
- CountryRepublic of Korea
-
Abstract:
Uterine myomas (fibroids) are the most common benign tumors in women and occur in 20%–40% of women of reproductive age. Myomas are benign monoclonal tumors that develop from the smooth muscle cells of the myometrium. Most pregnant women with myomas do not have complications during pregnancy, but complications can occur. Among the complications, pain is the most common, and the risks of miscarriage, preterm labor and delivery, abnormal positioning of the fetus, and placental abruption increase slightly. There are also concerns about the potential effects of uterine myomas on infertility and reproductive function. Therefore, there are frequent clinical concerns about the presence of myomas during pregnancy;however, the treatments are unclear. In this study, we summarize the latest trends in uterine myomas and pregnancy and consider the treatments.
